Nintedanib-Induced Delayed Mucosal Healing after Adjuvant Radiation in a Case of Oropharyngeal Carcinoma

Since the launch of imatinib in 2001, tyrosine kinase inhibitors are being used in chemotherapy for a wide range of malignant tumors. Drugs that inactivate multiple molecular mechanisms are called multikinase inhibitors (MKIs). Nintedanib is a type of MKI that inhibits downstream cascades in three s...

Descripción completa

Detalles Bibliográficos
Autores principales: Takahashi, Satoru, Endo, Masashi, Fukuda, Yukiko, Ogawa, Kazunari, Nakamura, Michiko, Okada, Kohei, Kawahara, Masahiro, Akahane, Keiko, Nagatomo, Takafumi, Onaga, Ryutaro, Nishino, Hiroshi, Mori, Harushi, Shirai, Katsuyuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9459593/
https://www.ncbi.nlm.nih.gov/pubmed/36157698
http://dx.doi.org/10.1159/000526077

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9459593/
https://www.ncbi.nlm.nih.gov/pubmed/36157698
http://dx.doi.org/10.1159/000526077

Ejemplares similares